AIM
RGEN icon

Acrospire Investment Management’s Repligen RGEN Stock Holding History

Acrospire Investment Management’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-900
Closed -$37K – 1123
2017
Q2 		$37K Buy
+900
New +$34.2K 0.03% 1134
2016
Q4 		– Sell
-1,137
Closed -$34K – 2387
2016
Q3 		$34K Sell
1,137
-2,200
-66% -$66.4K 0.02% 1283
2016
Q2 		$91K Sell
3,337
-600
-15% -$15.3K 0.07% 550
2016
Q1 		$106K Buy
+3,937
New +$96.3K 0.07% 287

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Acrospire Investment Management's RGEN Position: Q3 2017 in Review

Acrospire Investment Management sold out of Repligen (RGEN) in Q3 2017, closing a stake of 900 shares — an estimated $37K sold.

Acrospire Investment Management first reported a position in RGEN in Q1 2016 and held it in 4 quarters. The position peaked at $106K in Q1 2016. 190 funds tracked by Wall St. Rank hold RGEN as of Q3 2017.

  • Acrospire Investment Management reported no remaining Repligen position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 900 Repligen shares in Q3 2017, an estimated $37K.
  • Acrospire Investment Management first reported a position in Repligen in Q1 2016 and held it in 4 quarters.
  • Acrospire Investment Management's Repligen position peaked at $106K in Q1 2016.
  • 190 funds tracked by Wall St. Rank held Repligen as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.